[Current methods in the treatment of iatrogenic neutropenia]

Tumori. 2003 Nov-Dec;89(6):12-20. doi: 10.1177/030089160308900621.

[Article in Italian]

Authors

Fausto Meriggi¹, Alberto Zaniboni

Affiliation

¹ UO di Oncologia Medica, Poliambulanza, Brescia.

PMID: 14870835
DOI: 10.1177/030089160308900621

No abstract available

Publication types

Review

MeSH terms

Animals
Antineoplastic Agents / adverse effects
Clinical Trials as Topic
Fever / drug therapy
Fever / etiology
Granulocyte Colony-Stimulating Factor / therapeutic use*
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
Humans
Neutropenia / chemically induced*
Neutropenia / drug therapy*
Risk
Treatment Outcome

Substances

Antineoplastic Agents
Granulocyte Colony-Stimulating Factor
Granulocyte-Macrophage Colony-Stimulating Factor